Global Cardiovascular Disease Market Size Study, by Diseases (Hypertension, Dyslipidemia, Inflammatory Heart Disease, Ischemic Heart Disease, Others), by Treatment (Antiplatelet Agents, Beta-Blockers, Angiotensin-Converting Enzyme Inhibitors, Others), by Route of Administration (Oral, Parenteral, Others), by End-User (Hospitals, Homecare, Specialty Clinics, Others), by Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), and Regional Forecasts 2022-2032
2024/10/28
4,950 USD